Optical imaging of matrix metalloproteinase-2 activity in tumors: Feasibility study in a mouse model

Radiology

Volumn 221, Issue 2, 2001, Pages 523-529

  Bremer, C ^a   Bredow, S ^a   Mahmood, U ^a   Weissleder, R ^a   Tung, C H ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Animals; Enzymes; Experimental study; Molecular analysis; Neoplasms, experimental studies

Indexed keywords

GELATINASE A; GELATINASE INHIBITOR; RECOMBINANT ENZYME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SIGNAL PROCESSING; TUMOR CELL CULTURE; TUMOR MODEL;

EID: 0034760321     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2212010368     Document Type: Article

References (41)

1. Cancer: Proteases - Invasion and more
2. Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model
3. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer
4. Angiogenic zip code
5. MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma: A clinicopathologic study using immunohistochemistry and mRNA in situ hybridization
6. Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer
7. Membrane-type matrix metalloproteinase-1 expression and activation of gelatinase A as prognostic markers in advanced pediatric neuroblastoma
8. Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials
9. Marked antiangiogenic and antitumor efficacy of AG3340 in chemoresistant human non-small cell lung cancer tumors: Single agent and combination chemotherapy studies
10. Experimental and clinical studies on the use of matrix metalloproteinase inhibitors for the treatment of cancer
11. Marimastat in patients with advanced pancreatic cancer: A dose-finding study
12. Proteases and their inhibitors in human brain tumours: A review
13. Phase I/II trial of batimastat, a matrix metalloproteinase inhibitor, in patients with malignant ascites
14. Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340
15. Inhibition of gelatinase A (MMP-2) by batimastat and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma
16. Expression of matrix metalloproteinase-1, -2 and -3 in squamous cell carcinoma and actinic keratosis
17. Increase in interphotoreceptor matrix gelatinase A (MMP-2) associated with age-related macular degeneration
18. A continuous fluorescence-based assay of human cytomegalovirus protease using a peptide substrate
19. Matrix metalloproteinases, tissue inhibitors of metalloproteinases, and glycosaminoglycans in synovial fluid from patients with rheumatoid arthritis
20. Matrix metalloproteinases and cardiovascular disease
21. Cytokines secreted by glial cells infected with HTLV-I modulate the expression of matrix metalloproteinases (MMPs) and their natural inhibitor (TIMPs): Possible involvement in neurodegenerative processes
22. Preparation of a cathepsin D sensitive near-infrared fluorescence probe for imaging
23. A long-circulating co-polymer in "passive targeting" to solid tumors
24. Cleavage specificity of human skin type IV collagenase (gelatinase): Identification of cleavage sites in type I gelatin, with confirmation using synthetic peptides
25. Increased incidence of matrix metalloproteinases in urine of cancer patients
26. Overview of matrix metalloproteinase expression in cultured human cells
27. In vivo imaging of proteolytic activity using a novel molecular reporter
28. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen
29. Hypothalamic growth hormone-releasing hormone mRNA varies across the day in rats
30. Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines
31. Near-infrared optical imaging of protease activity for tumor detection
32. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes
33. Suicidal tumor proteases
34. Matrix metalloproteinases: Biologic activity and clinical implications
35. Changing views of the role of matrix metalloproteinases in metastasis
36. A matrix metalloproteinase expressed on the surface of invasive tumour cells
37. In vivo assessment of vascular endothelial growth factor-induced angiogenesis
38. Near-infrared images using continuous, phase-modulated, and pulsed light with quantitation of blood and blood oxygenation
39. Scattering of diffuse photon density waves by spherical inhomogeneities within turbid media: Analytic solution and applications
40. Fluorescence tomographic imaging in turbid media using early-arriving photons and Laplace transforms
41. Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement